Clinical and molecular surveillance of drug resistant vivax malaria in Myanmar (2009-2016).

ABSTRACT:

Background

One of the major challenges for control and elimination of malaria is ongoing spread and emergence of drug resistance. While epidemiology and surveillance of the drug resistance in falciparum malaria is being explored globally, there are few studies on drug resistance vivax malaria.

Methods

To assess the spread of drug-resistant vivax malaria in Myanmar, a multisite, prospective, longitudinal study with retrospective analysis of previous therapeutic efficacy studies, was conducted. A total of 906 from nine study sites were included in retrospective analysis and 208 from three study sites in prospective study. Uncomplicated vivax mono-infected patients were recruited and monitored with longitudinal follow-up until day 28 after treatment with chloroquine. Amplificat

SUBMITTER: Nyunt MH 

PROVIDER: S-EPMC5353783 | biostudies-literature | 2017 Mar

REPOSITORIES: biostudies-literature